Showing 1,341 - 1,360 results of 2,530 for search '"vaccines"', query time: 0.08s Refine Results
  1. 1341

    COVID-19: An Update on the Latest Therapeutic Agents by Ke-Yan Loo, Loh Teng-Hern Tan, Jodi Woan-Fei Law, Kar-Wai Hong, Kok-Gan Chan, Vengadesh Letchumanan

    Published 2023-04-01
    “…Vaccines against the viral infection started rolling out in late 2020, and the distribution of the vaccines worldwide managed to reduce the symptoms of COVID-19 and prevent outbreaks in local communities. …”
    Get full text
    Article
  2. 1342

    Canada’s National Advisory Committee on Immunization: Celebrating 50 Years by Shalini Desai, Shainoor J lsmail, Robert Lerch, Bryna F Warshawsky, Ian Gemmill

    Published 2015-01-01
    “…Vaccines have saved more lives than any other innovation in modern medicine. …”
    Get full text
    Article
  3. 1343

    Advances in Immunotherapy for Melanoma: A Comprehensive Review by Carmen Rodríguez-Cerdeira, Miguel Carnero Gregorio, Adriana López-Barcenas, Elena Sánchez-Blanco, Beatriz Sánchez-Blanco, Gabriella Fabbrocini, Brunilda Bardhi, Ardiana Sinani, Roberto Arenas Guzman

    Published 2017-01-01
    “…Several types of vaccines, including peptide, viral, and dendritic cell vaccines, are currently under investigation for the treatment of melanoma. …”
    Get full text
    Article
  4. 1344
  5. 1345
  6. 1346
  7. 1347

    Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use by Yu Zhang, Ke Qiu, Jianjun Ren, Yu Zhao, Ping Cheng

    Published 2025-01-01
    “…Although various therapeutic vaccines have been developed and tested clinically, none of them have been officially approved to date. …”
    Get full text
    Article
  8. 1348

    Avian adenovirus infections: diversity of pathogens, hazard to poultry industry and problems of immunoprophylaxis (review) by Yu. R. Zelenskiy, M. S. Volkov, I. A. Komarov, N. V. Moroz, N. S. Mudrak, T. V. Zhbanova

    Published 2024-03-01
    “…There is no registered vaccine against adenovirus infections that cause inclusion body hepatitis and adenoviral gizzard erosion. …”
    Get full text
    Article
  9. 1349

    Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: A Delphi panel by Kate Halsby, Gerhard Dobler, Ava Easton, Guntis Karelis, Lenka Krbková, Jan Kyncl, Johann Sellner, Franc Strle, Malin Veje, Joanna Zajkowska, Dace Zavadska, Frederick J. Angulo, Andreas Pilz, Wilhelm Erber, Meghan Gabriel, Jon Russo, Mark Price, Harish Madhava, Uta Katharina Meyding-Lamadé

    Published 2025-01-01
    “…Development of a clinical categorisation system will enhance patient care and foster comparability among studies, thereby supporting treatment development, refining vaccine strategies, and fortifying public health surveillance.…”
    Get full text
    Article
  10. 1350
  11. 1351

    Updated COVID-19 Condition in Australia by Ke-Yan Loo, Vengadesh Letchumanan, Loh Teng-Hern Tan, Jodi Woan Fei Law

    Published 2021-12-01
    “…In late 2020, vaccines were finally ready to be distributed globally to reduce the severity of the disease and fatalities. …”
    Get full text
    Article
  12. 1352

    KAP of influenza, streptococcal pneumonia, and herpes zoster among community-dwelling older adults with chronic diseases in Nanjing city: a cross-sectional survey by Zhengkai SHEN, Siyu TIAN, Zhiyong WANG, Wenjing ZHU, Lirong DONG, Jinshui XU

    Published 2024-10-01
    “…Only 7% of the participants disagreed with the statement "very concerned about side effects of the vaccines" and 58.3% were more likely to accept vaccination recommendations from doctors. …”
    Get full text
    Article
  13. 1353

    Тransplastomic tobacco plants producing the hydrophilic domain of the sheep pox virus coat protein L1R by D. K. Beisenov, G. E. Stanbekova, B. K. Iskakov

    Published 2020-12-01
    “…Such vaccines are effective, but potentially dangerous because of the possible virus reversion to a pathogenic state. …”
    Get full text
    Article
  14. 1354

    The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook by Hager Mohamed, Vandana Miller, Stephen R. Jennings, Brian Wigdahl, Fred C. Krebs

    Published 2020-01-01
    “…Dendritic cells have thus been recognized as a valuable tool in the development of immunotherapeutic approaches and vaccines effective against HIV-1. The advancements in dendritic cell vaccines in cancers have paved the way for applications of this form of immunotherapy to HIV-1 infection. …”
    Get full text
    Article
  15. 1355
  16. 1356

    Questions from the fourth son: A clinician reflects on immunomonitoring, surrogate markers and systems biology by Charles Wiseman, M.D.

    Published 2011-03-01
    “…Unlike prophylactic vaccines for infectious disease, where the development of antibody is considered a satisfactory endpoint, no such endpoint exists for human therapeutic vaccines. …”
    Get full text
    Article
  17. 1357

    South Africa’s Battle Against COVID-19 Pandemic by Ke Yan Loo, Jodi Woan-Fei Law, Loh Teng Hern Tan, Vengadesh Letchumanan

    Published 2022-02-01
    “…An eight-stage program to combat COVID-19 and a national vaccination strategy was also developed soon to manage the Coronavirus spread in the country better. …”
    Get full text
    Article
  18. 1358

    Influenza Surveillance in an Urban Area by W Paul Glezen

    Published 1993-01-01
    “…Improved coverage with more immunogenic vaccines is needed to protect the elderly. Young children would benefit from universal immunization with available live attenuated vaccines.…”
    Get full text
    Article
  19. 1359

    A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies by Reza Panahizadeh, Padideh Panahi, Vahid Asghariazar, Shima Makaremi, Ghasem Noorkhajavi, Elham Safarzadeh

    Published 2025-01-01
    “…Main body This review examines over 160 clinical studies conducted globally, focusing on the effectiveness of various immunotherapy modalities, including cancer vaccines, adoptive cell therapy, immune checkpoint inhibitors (ICIs), and monoclonal antibodies (mAbs). …”
    Get full text
    Article
  20. 1360